#240 Psychedelics: Is This Why They’re Investing? (With Nicolas Glynos)


Manage episode 329984886 series 2609516
Stworzone przez Russell Brand, odkryte przez Player FM i naszą społeczność - prawa autorskie są własnością wydawcy, a nie Player FM, a dzwięk jest przesyłany bezpośrednio z ich serwerów. Naciśnij przycisk Subskrybuj, aby śledzić aktualizacje Player FM, lub wklej adres URL kanału do innych aplikacji podcastowych.

This week I spoke with Nicolas Glynos, who is Vice President of the Student Association for Psychedelic Studies and Co-founder of Psychedelic Neuroscience and Therapy for the University of Michigan. His latest work is focused on the compound DMT (N, N- Dimethyltryptamine), which exists within our bodies as well as throughout nature. (It's sometimes called "the spirit molecule.") Together we talk about the neurological picture of the brain when DMT has been administered--for instance, the impact DMT has on default brain network functions such as "mental time-travel/mind wandering" and "planning"--as well as all the other ways to measure the brain under psychedelics. Plus, we find out about the plant-based psychedelic ayahuasca.

More Info:

See Nicolas’ TED Talk, here https://www.youtube.com/watch?v=LFnCwXPjSCk

Join me for a 10-minute meditation over on my other podcast Above the Noise.

Join my mailing list and find out more about a one-off special with Wim Hof on July 10th and other exclusive news from my weekly bulletins too. https://www.russellbrand.com/join

205 odcinków